Quidel Corp.
NASDAQ:QDEL
| Market Cap (Intraday) | 6.86B |
| Current PE | 8.46 |
| Forward PE | 4.76 |
| 2yr Forward PE | 13.33 |
| 10-Day MA | $181.29 |
| 50-Day MA | $206.46 |
| 200-Day MA | $214.04 |
Quidel Corp. Stock, NASDAQ:QDEL
9975 Summers Ridge Road, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.552.1100
Number of Employees: 1370
Description
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.